Country, Europe, WorldwideBioNTech says it will start cancer vaccine trials in the UK from SeptemberJanuary 9, 2023January 13, 2023 The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.